INTECH Investment Management’s Maravai LifeSciences MRVI Stock Holding History

INTECH Investment Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$161K	Sell	25,762 -2,580	-9%	-$11.1K	﹤0.01%	1847
2026 Q1	$80.2K	Sell	28,342 -25,860	-48%	-$87.7K	﹤0.01%	1935
2025 Q4	$176K	Sell	54,202 -7,219	-12%	-$24.3K	﹤0.01%	2028
2025 Q3	$176K	Sell	61,421 -10,744	-15%	-$27.4K	﹤0.01%	2112
2025 Q2	$174K	Sell	72,165 -13,424	-16%	-$28.2K	﹤0.01%	2135
2025 Q1	$189K	Buy	85,589 +35,909	+72%	+$142K	﹤0.01%	2115
2024 Q4	$271K	Buy	49,680 +25,668	+107%	+$165K	﹤0.01%	1882
2024 Q3	$200K	Buy	+24,012	New	+$208K	﹤0.01%	1720
2023 Q3	–	Sell	-14,113	Closed	-$175K	–	744
2023 Q2	$175K	Buy	+14,113	New	+$190K	﹤0.01%	698

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

INTECH Investment Management's MRVI Position: Q2 2026 in Review

INTECH Investment Management reduced its Maravai LifeSciences (MRVI) stake by 9.1% in Q2 2026, selling an estimated $11.1K and leaving 25,762 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #1847.

INTECH Investment Management first reported a position in MRVI in Q2 2023 and has held it in 9 quarters since. The position peaked at $271K in Q4 2024. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

INTECH Investment Management held 25,762 shares of Maravai LifeSciences worth $161K as of Q2 2026.
INTECH Investment Management sold 2,580 Maravai LifeSciences shares in Q2 2026, an estimated $11.1K.
Maravai LifeSciences made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1847 holding.
INTECH Investment Management first reported a position in Maravai LifeSciences in Q2 2023 and has held it in 9 quarters since.
INTECH Investment Management's Maravai LifeSciences position peaked at $271K in Q4 2024.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.